ProKidney appoints Kenneth Locke as chief technical officer
Summary
ProKidney named Kenneth Locke as its new chief technical officer. The company operates in late-stage cell therapy, so this appointment supports its technical and development execution. This type of move often signals continued investment in clinical, manufacturing, or platform capabilities. For vendors and partners, it can indicate upcoming needs around life sciences technology, data systems, and development support.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected